The results showed that the expression of CTSG, MMP9, PRTN3, RETN, RNASE2, and RNASE3 were dramatically upregulated in CML-CP comparing to the normal cells (P < 0.001). The gene discussed is RNASE2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.